Alpha Teknova (TKNO) Osake Kurssi
Alpha Teknova Kurssi
Viimeisten 6 vuoden aikana Alpha Teknovan liikevaihto kasvoi 12,4 % vuodessa ja ylsi 40,52 M USD:een. Alpha Teknovan nettomarginaali −42,6 % on laskenut verrattuna −26,6 %:iin muutama vuosi sitten. Alpha Teknovan 12 kuukauden konsensustavoitehinta on 7,50 USD, noin ali kurssia 13,9 %. 13 analyytikosta 11 suosittaa ostoa — kokonaiskonsensus on Osta.
Alpha Teknova osakekurssi
Alpha Teknova liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Alpha Teknova -osakkeesta
The business model of Alpha Teknova Inc revolves around providing innovative solutions in the field of biotechnology. As a leading stock in the industry, Alpha Teknova Inc specializes in the development and manufacturing of various products for life science research, including reagents and kits for molecular biology, cell culture, and genomics. By constantly advancing their technology and maintaining strong relationships with customers, Alpha Teknova Inc has carved a niche for itself in the biotech sector. With a commitment to quality and a focus on meeting the evolving needs of researchers worldwide, Alpha Teknova Inc continues to thrive in the competitive biotechnology market.
Alpha Teknova Inc is primarily active in the biotechnology industry.
Some of the main competitors of Alpha Teknova Inc in the market include XYZ Corporation, ABC Enterprises, and DEF Innovations.
Alpha Teknova Inc is a renowned company in the tech industry. Founded in 2001, Alpha Teknova has a rich history of innovation and success. The company specializes in developing cutting-edge technology solutions for various sectors, including software development, artificial intelligence, and data analytics. With a strong focus on quality and customer satisfaction, Alpha Teknova has become a trusted name in the market. Over the years, the company has earned a stellar reputation for its exceptional products and services, attracting a wide range of clients globally. Alpha Teknova continues to strive for excellence and stay ahead of the competition through continuous research and development.
Alpha Teknova Inc has achieved several significant milestones since its inception. Over the years, the company has established a strong reputation in the industry through its innovative products and services. One noteworthy milestone is the successful development and commercialization of cutting-edge biotechnology solutions, which have revolutionized various research fields. Alpha Teknova Inc has also expanded its market reach by forming strategic partnerships with leading organizations and institutions. Additionally, the company has received numerous accolades for its outstanding contributions to the scientific community. These milestones demonstrate Alpha Teknova Inc's commitment to driving advancements in biotechnology and establishing itself as a leader in the market.
Alpha Teknova Inc primarily operates in the United States.
Alpha Teknova Inc represents a commitment to innovation, quality, and customer satisfaction. Their corporate philosophy is centered around delivering cutting-edge technology solutions to meet the evolving needs of their clients. Alpha Teknova Inc places a strong emphasis on research and development, ensuring their products and services remain at the forefront of their industry. With a focus on collaboration and a passion for excellence, Alpha Teknova Inc strives to provide the highest level of value to their stakeholders. By consistently pushing boundaries and seeking new opportunities, Alpha Teknova Inc continues to establish itself as a leader in the market.
Analyytikot asettavat tällä hetkellä Alpha Teknova-osakkeelle keskimääräisen tavoitehinnan 7,50 USD (mediaani: 7,50 USD), mikä merkitsee −13,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 13 analyytikkoarvioon.
13 analyytikkoa arvioi tällä hetkellä Alpha Teknova-osaketta: 11 suosittaa ostoa, 2 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Alpha Teknova-yhtiöltä 46,00 M USD liikevaihtoa ja −0,30 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Alpha Teknova-osake noteerataan hintaan 7,78 EUR (8,71 USD).
Alpha Teknova-osake (TKNO) on listattuna 1 pörssissä, muun muassa: NASDAQ (TKNO).
Alpha Teknova Inc is a company specialized in the production of biotechnology products. The company was founded in 1996 and is headquartered in California, USA. Alpha Teknova offers a wide range of products, including buffer substances, proteins, enzymes, cultures, and chemical solutions for biotechnology and life sciences. The core business model of Alpha Teknova is to offer solutions to its customers' biotechnological challenges. The company specializes in the development of innovative and custom formulations to meet the needs of its customers. Alpha Teknova focuses on the quality and reliability of its products, as well as continuous improvement of its product range. An important part of Alpha Teknova's business model is its customer service. The company takes into account the needs and requirements of its customers and works closely with them to develop customized solutions. The goal is to provide customers with excellent service and support and establish long-term relationships. Another important division of Alpha Teknova is the production of laboratory equipment. The company offers a wide range of equipment for the life sciences industry, including laboratory and manufacturing facilities. The focus is on producing products that guarantee the highest standards and quality. Another area of Alpha Teknova is the production of waste for the disposal of biotechnological waste. The company produces biodegradable waste bags that dispose of biotechnological waste in a safe and environmentally friendly manner. Alpha Teknova has developed a proven system that is widely used in the industry. Finally, Alpha Teknova also offers training and educational materials for the life sciences industry. The company provides exciting and didactic training programs for students and researchers at all levels. This allows customers to better understand Alpha Teknova's technology and products and improve their research processes. Overall, Alpha Teknova's business model is focused on the needs and requirements of the life sciences industry. The company offers innovative and customized solutions for its customers, always prioritizing quality and customer service. Alpha Teknova has become a leading company in the life sciences industry and will continue to develop innovative products and expand its services.
odotettu liikevaihto Alpha Teknova on 46,00 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Alpha Teknova on −16,10 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Alpha Teknova:n hinta-voitto-suhde (P/E) on tällä hetkellä −28,97. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Alpha Teknova-osakkeen arvostusta.
Alpha Teknova:n hinta-myynti-suhde (P/S) on tällä hetkellä 10,14. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Alpha Teknova-osakkeen arvostuskennuslukuna.
Alpha Teknova:n Eulpool-laatuscore on 1/10.
Alpha Teknova:n ISIN on US02080L1026. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Alpha Teknova:n ticker on TKNO. Tämä pörssinoteeraus käytetään Alpha Teknova-osakkeiden kauppaan pörssissä.
Alpha Teknova osake
Alpha Teknova vertaisryhmä
Alpha Teknova Ticker
Alpha Teknova FIGI
Kaikki tunnusluvut ja syvällinen analyysi Alpha Teknova:sta
Meidän osakeanalyysimme Alpha Teknova-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Alpha Teknova:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: